Skip to content

Polysorbates in Pharmaceutical Products

Challenges and Control Strategies

 

Visible Particle Identification
Visible Particle Identification
Read More
Contents
CTA goes here
Contents

Polysorbates, the Good, the Bad and the Ugly

Polysorbates—especially Polysorbate 20 (PS20) and Polysorbate 80 (PS80)—are critical non-ionic surfactants used in almost all biologic drug products. Their primary role is to stabilize protein-based active pharmaceutical ingredients (APIs) against interfacial stresses during manufacturing, storage, and administration. Despite their long-standing use and regulatory acceptance, polysorbates pose complex challenges that can compromise drug safety and efficacy if not effectively controlled.

Polysorbate structural heterogeneity

One of the key challenges arises from the inherent structural heterogeneity of commercial polysorbate products. These surfactants are produced from natural sources like coconut or palm oil under harsh chemical conditions, leading to chemically diverse mixtures. Canonical polysorbate structures often constitute less than 20% of their total composition, with the rest comprising impurities and byproducts. Variability across suppliers, grades, and batches can affect polysorbate degradation and product stability.

Polysorbate Degradation

Degradation is a major concern. Polysorbates are susceptible to hydrolysis and oxidation. Enzymatic hydrolysis, typically driven by residual host cell proteins (HCPs) such as lipases, is the primary degradation mechanism. Even trace amounts of these enzymes can break down polysorbates into free fatty acids, which may lead to the formation of visible and subvisible particles. 
Operational risks include polysorbate loss via adsorption to manufacturing equipment (e.g., filters or IV bag components), interactions with silicone oil in pre-filled syringes, and dilution effects during administration. Such losses may reduce protective capacity, leading to protein aggregation or underdosing.

Polysorbate Analytical Tool Box

Characterization and control of Polysorbate degradation require a holistic analytical approach. At Clear Solutions Laboratories, a specialized toolbox supports both routine QC and in-depth investigations. Quantification methods include fluorescence micelle assays and universal detection via ELSD or CAD enables Polysorbate profiling. Extended characterization employs mass spectrometry for fatty acid characterization and while flow imaging microscopy and FTIR techniques are used for particle identification.

Furthermore, a lipolytic activity assays can support assessing enzymatic mediated Polysorbate degradation. It helps establish correlations between lipase activity and polysorbate degradation, supports root cause analysis and guides improvements in downstream purification processes. This assay is especially valuable when traditional HCP thresholds fail to predict degradation due to low yet active lipase levels.

The Need for a Hollistic Polysorbate Control Strategy

To mitigate these risks, Clear Solutions Laboratories recommends implementing an end-to-end polysorbate control strategy. This includes controlling raw material variability, optimizing downstream purification to minimize lipase content, applying robust quantitative and qualitative analytical methods, and potentially integrating product-specific polysorbate specifications into the control strategy.

In conclusion, while polysorbates are indispensable excipients in biologic drug formulations, their complex nature and susceptibility to degradation necessitate proactive monitoring and tailored control strategies. Clear Solutions Laboratories provides the scientific expertise and analytical capabilities needed to ensure polysorbate stability.

Video description/title here

Video Thumbnail
×

Visual Inspection Pharma

  • Ensuring compliance with global regulatory requirements for visual inspection of injectables
  • Detecting visible particles and container defects with high accuracy
  • Balancing manual, semi-automated, and fully automated inspection methods
  • Implementing risk-based approaches for defect classification and control
  • Supporting robust quality assurance to protect patient safety
Learn more

Visual Inspection Test Sets in Pharma

  • Establishing reliable qualification of manual and automated inspection systems
  • Providing standardized reference sets to train and requalify human inspectors
  • Ensuring realistic representation of product-specific particle risks
  • Supporting statistical evaluation of probability of detection (POD)
  • Reducing risk of recalls by maintaining validated inspection performance
Learn more

Technical bulletins on visual inspection, particle control and polysorbate degradation

Learn more

Scientific Precision

Real-World Impact

CLS_Group_

Meet the people behind Clear Solutions Labs – where advanced analytics meets pharmaceutical innovation.

At Clear Solutions Labs, science meets purpose. Our team of experts delivers customized analytical solutions to support pharmaceutical companies in research, development, and quality control. Whether it’s complex formulation testing, spectroscopic data analysis, or regulatory compliance support, we bring clarity to complexity.